Table 1.
PH Patients (n = 53) | Control Subjects (n = 53) | P Value | |
---|---|---|---|
Age, yr (range) | 8 (0 - 23) | 8 (0 - 23) | 0.99 |
Female, n (%) | 34 (64.2%) | 34 (64.2%) | 1.00 |
Weight, kg | 32.5 (14.7 - 51.4) | 30.6 (16.3 - 54.8) | 0.20 |
Height, cm | 133.0 (98.0 - 161.0) | 136.0 (104.5 - 162.0) | 0.11 |
Body Surface Area, m2 | 1.12 (0.63 - 1.52) | 1.10 (0.69 - 1.57) | 0.06 |
Heart Rate, bpm | 81 (70 - 100) | 79 (65 - 93) | 0.09 |
Congenital Heart Disease, n (%) | 33 (62.3%) | ... | ... |
Atrial Septal Defect / Patent Foramen Ovale | 24 (45.3%) | ... | ... |
Ventricular Septal Defect | 5 (9.4%) | ... | ... |
Patent Ductus Arteriosus | 11 (20.8%) | ... | ... |
Other | 5 (9.4%) | ... | ... |
Shunt Present at Catheterization, n (%) | 21 (39.6%) | ... | ... |
Idiopathic Pulmonary Arterial Hypertension | 14 (26.4%) | ... | ... |
World Health Organization Class, n (%) | |||
Not Available | 15 (28.3%) | ... | ... |
I / II | 15 (28.3%) / 16 (30.2%) | ... | ... |
III / IV | 6 (11.3%) / 1 (1.9%) | ... | ... |
Presented as n (%) or median (interquartile range), unless otherwise noted. PH indicates pulmonary hypertension.